NCT05956899View on ClinicalTrials.gov

Palonosetron vs Ondansetron In PONV Prophylaxis Among Idiopathic Scoliosis Patients

PHASE4CompletedINTERVENTIONAL
Enrollment

92

Participants

Timeline

Start Date

June 1, 2023

Primary Completion Date

March 20, 2024

Study Completion Date

May 2, 2024

Conditions
Idiopathic ScoliosisPostoperative Nausea and Vomiting
Interventions
DRUG

Palonosetron

IV palonosetron 1.5mcg/kg prior to commencement of general anaesthesia

DRUG

Ondansetron

IV ondansetron 0.15mg/kg at the start of wound closure

Trial Locations (1)

59100

University Malaya, Pantai Valley

All Listed Sponsors
lead

University of Malaya

OTHER

NCT05956899 - Palonosetron vs Ondansetron In PONV Prophylaxis Among Idiopathic Scoliosis Patients | Biotech Hunter | Biotech Hunter